Cargando…
Experimental Treatment of SIV-Infected Macaques via Autograft of CCR5-Disrupted Hematopoietic Stem and Progenitor Cells
Hematopoietic stem cell (HSC)-based gene therapy targeting CCR5 represents a promising way to cure human immunodeficiency virus type 1 (HIV-1) infection. Yet the preclinical animal model with transplantation of autologous CCR5-ablated HSCs remains to be optimized. In this study, four Chinese rhesus...
Autores principales: | Yu, Songlin, Ou, Yang, Xiao, Hongkui, Li, Jiaojiao, Adah, Dickson, Liu, Shiquan, Zhao, Siting, Qin, Li, Yao, Yongchao, Chen, Xiaoping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114624/ https://www.ncbi.nlm.nih.gov/pubmed/32258215 http://dx.doi.org/10.1016/j.omtm.2020.03.004 |
Ejemplares similares
-
Subsequent malaria enhances virus-specific T cell immunity in SIV-infected Chinese rhesus macaques
por: Liu, Guangjie, et al.
Publicado: (2022) -
CCR5 Inhibition Prevents Cardiac Dysfunction in the SIV/Macaque Model of HIV
por: Kelly, Kathleen M., et al.
Publicado: (2014) -
Engineering SIV-resistant macaque hematopoietic stem cells and CD4+ T cells with CCR5-specific zinc-finger nucleases
por: Bonello, G, et al.
Publicado: (2012) -
Plasmodium infection reduces the volume of the viral reservoir in SIV-infected rhesus macaques receiving antiretroviral therapy
por: Zhan, Xiao-Yong, et al.
Publicado: (2014) -
Preclinical development and qualification of ZFN-mediated CCR5 disruption in human hematopoietic stem/progenitor cells
por: DiGiusto, David L, et al.
Publicado: (2016)